15 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19298798 | ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY | SINGH, ANOOP KUMAR | 1632 | Non-Final OA | Aug 13, 2025 |
| 18513227 | Methods of Treating Muscular Dystrophy | BERTOGLIO, VALARIE E | 1632 | Final Rejection | Nov 17, 2023 |
| 18287677 | PRODUCTS AND METHODS FOR TREATING MUSCULAR DYSTROPHY | REGA, KYLE THOMAS | 1636 | Non-Final OA | Oct 20, 2023 |
| 18201572 | PM21 PARTICLES TO IMPROVE BONE MARROW HOMING OF NK CELLS | STOICA, ELLY GERALD | 1647 | Non-Final OA | May 24, 2023 |
| 17920231 | EPHA4 TARGETING COMPOUNDS AND METHODS OF USE THEREOF | BOWLES, DAVID PAUL | 1654 | Non-Final OA | Oct 20, 2022 |
| 17910992 | NK CELLS AND USES THEREOF FOR TREATMENT OF MICROBIAL INFECTIONS | WILSON, MICHAEL C | 1638 | Non-Final OA | Sep 12, 2022 |
| 17786721 | OPTIMIZED GENE THERAPY FOR TARGETING MUSCLE IN MUSCLE DISEASES | CHOWDHURY, IQBAL HOSSAIN | 1656 | Non-Final OA | Jun 17, 2022 |
| 17830871 | Recombinant Adeno-Associated Virus Products and Methods for Treating Limb Girdle Muscular Dystrophy 2A | CONNORS, ALEXANDRA F | 1634 | Final Rejection | Jun 02, 2022 |
| 17650273 | SMART MUSCLE TESTING DEVICES AND METHODS FOR USE THEREOF | HOEKSTRA, JEFFREY GERBEN | 3791 | Final Rejection | Feb 08, 2022 |
| 17511187 | CHIMERIC ANTIGEN RECEPTOR (CAR) NK CELLS AND USES THEREOF | ZHU, JIANJIAN | 1631 | Non-Final OA | Oct 26, 2021 |
| 17604188 | GENE THERAPY FOR TREATING OR PREVENTING VISUAL EFFECTS IN BATTEN DISEASE | STAVROU, CONSTANTINA E | 1632 | Non-Final OA | Oct 15, 2021 |
| 17439092 | COMPOSITIONS AND METHODS FOR DIAGNOSING ACUTE INFECTIOUS PERITONITIS | IVICH, FERNANDO NMN | 1678 | Final Rejection | Sep 14, 2021 |
| 17432398 | CANCER-TARGETED, VIRUS-ENCODED, REGULATABLE T (CATVERT) OR NK CELL (CATVERN) LINKERS | EDGINGTONGIORDANO, FRANCESCA | 1643 | Final Rejection | Aug 19, 2021 |
| 17431276 | USE OF A STIMULATING AGENT TO ASSAY IMMUNE CELL POTENCY | FAUST, AMBER KATHLEEN | 1643 | Final Rejection | Aug 16, 2021 |
| 17272194 | GENE THERAPY FOR THE TREATMENT OF GALACTOSEMIA | NGUYEN, QUANG | 1631 | Non-Final OA | Feb 26, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial